Recombinant and amplicon vectors derived from herpes simplex virus typ
e 1 (HSV-1) have proven to be an efficient means of gene delivery to c
ells in culture and in vivo, In this study, a system was developed to
make propagation of the amplicon vector and helper virus mutually depe
ndent on each other, in a 'piggyback' fashion, This combined system su
pports maintenance and enrichment of the amplicon vector when propagat
ing stocks, while allowing the helper virus to serve as a recombinant
vector in its own right, Amplicons bearing a gene essential for HSV-1
replication, IE3, as well as the Escherichia coil lacZ marker gene, we
re propagated using a mutant virus (d120) deleted in the same essentia
l gene, Vector stocks could be propagated in Vero cells and other cult
ured cells not transfected with the IE3 gene with markedly delayed cyt
opathic effects, as compared to wild-type virus. Relatively high titer
s of amplicon vectors (6 x 10(7) infectious units/ml) were achieved wi
th this piggyback system in Vero cells, with an apparent ratio of ampl
icon vector: helper virus of up of 5:1 under some conditions; however,
recombinant wild-type virus was also generated, Injection of these st
ocks into experimental gliomas in rodent brain revealed gene delivery
to tumor cells mediated by both amplicon vectors (lacZ) and helper vir
us (HSV-thymidine kinase), with no apparent neuropathology of normal b
rain, This basic piggyback vector model is amenable to modifications t
o promote conditional propagation of vectors in vivo and to allow inco
rporation of multiple transgene elements into both the amplicon and re
combinant helper virus vectors.